Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mersana Therapeutics Inc.

0.3245
+0.00772.43%
Post-market: 0.32960.0051+1.57%19:58 EDT
Volume:1.92M
Turnover:612.83K
Market Cap:40.44M
PE:-0.57
High:0.3386
Open:0.3300
Low:0.3110
Close:0.3168
Loading ...
Feb 28, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Dec 23, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Nov 27, 2019

Major Issues Report

Current report, items 1.01, 3.02, and 9.01
Nov 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 09, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Aug 21, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 08, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 26, 2019

Major Issues Report

Current report, item 5.02
Jul 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities